Companies/1CM Inc.

Company profile

1CM Inc.

OTC: MILFF · Healthcare · Drug Manufacturers - Specialty & Generic

Canadian filerHQ Markham, ONReports USD

#425 of 1,394 Healthcare companies by revenue70th-percentile growth

EA Score

70B

FH 79DQ —GM 58SS 43

v0.1 · 45/100 weight · provisional

↑ 3-yr revenue growth, Piotroski F · ↓ growth stability, listing tenure

Methodology →

Revenue TTM

$54.1M

Rev growth YoY (TTM)

+11.9%

Net income (FY)

$347.0k

Employees

—

Market cap

$9.2M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$52.5M73.3M CAD2025

Net income$347.0k484.5k CAD2025

Operating income$1.2M1.6M CAD2025

Total assets$31.6M43.5M CAD2025

Liabilities$10.7M14.6M CAD2025

Equity$21.0M28.8M CAD2025

Revenue trend

FY2018 – FY2025 · USD

$64.4k

FY18

$89.4k

FY19

$54.0k

FY20

$269.4k

FY21

$662.3k

FY22

$26.2M

FY23

$42.1M

FY24

$52.5M

FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

1CM Inc. booked $52.5M in FY2025 revenue, growing 25% year over year — faster than most Healthcare companies we track, at a 0.7% net margin.

Peers · Healthcare

Qscreen Ai Inc.——Quoin Pharmaceuticals, Ltd.38D Medicus Pharma Ltd. Common Stock——PharmaCielo Ltd.40D

Key facts

CEOTanvi Bhandari

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersMarkham, ON

ExchangeOTC: MILFF

Employees—

IPO date2018-07-20

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.